Cargando…

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats

A low concentration of nitric oxide associated with a high concentration of asymmetric dimethylarginine (ADMA) can explain the lack of ischemic cardioprotection observed in the presence of hypercholesterolemia. The objective of the present study was to evaluate the effect of hypercholesterolemia on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landim, M.B.P., Dourado, P.M.M., Casella-Filho, A., Chagas, A.C.P., da-Luz, P.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2013
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854396/ https://www.ncbi.nlm.nih.gov/pubmed/23681289 http://dx.doi.org/10.1590/1414-431X20132595

Ejemplares similares

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
por: Kocayiğit, İbrahim, et al.
Publicado: (2020)

Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Erre, Gian Luca, et al.
Publicado: (2019)

Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
por: Szabo, Zsuzsanna, et al.
Publicado: (2020)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA)
por: Arlouskaya, Yana, et al.
Publicado: (2019)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Risk of Cardiovascular Diseases in Diabetes Mellitus and Serum Concentration of Asymmetrical Dimethylarginine
por: Jawalekar, Seema L., et al.
Publicado: (2013)

Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control
por: Hsu, Chiao-Po, et al.
Publicado: (2014)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis
por: Davis, Joshua S., et al.
Publicado: (2011)

Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning
por: Baranyai, Tamás, et al.
Publicado: (2015)

Asymmetric and symmetric dimethylarginines: metabolism and role in severe sepsis
por: Umbrello, M, et al.
Publicado: (2009)

Diabetic Retinopathy Is Associated With Elevated Serum Asymmetric and Symmetric Dimethylarginines
por: Abhary, Sotoodeh, et al.
Publicado: (2009)

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria
por: Sibal, Latika, et al.
Publicado: (2009)

Left ventricular diastolic dysfunction and plasma asymmetric dimethylarginine concentration in persons with essential hypertension
por: Poręba, Rafał, et al.
Publicado: (2015)

Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients
por: Potočnjak, Ines, et al.
Publicado: (2018)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)

Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
por: Xuan, Chao, et al.
Publicado: (2016)

The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine
por: Taghikhani, Emir, et al.
Publicado: (2019)

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study
por: Surdacki, Andrzej, et al.
Publicado: (2013)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
por: Zobel, Emilie H., et al.
Publicado: (2017)

Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats
por: ZHONG, WEI, et al.
Publicado: (2015)

Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)
por: Scott, Jeremy A., et al.
Publicado: (2014)

Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration
por: Alkaitis, Matthew S., et al.
Publicado: (2015)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Live and let die: asymmetric dimethylarginine and septic shock
por: Böger, Rainer H
Publicado: (2006)

Mechanism of Cellular Oxidation Stress Induced by Asymmetric Dimethylarginine
por: Mohan, Srinidi, et al.
Publicado: (2012)

The Biological Axis of Protein Arginine Methylation and Asymmetric Dimethylarginine
por: Fulton, Melody D., et al.
Publicado: (2019)

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
por: Czarnecka, Anna, et al.
Publicado: (2016)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
por: Atıcı, Adem, et al.
Publicado: (2019)

Cadmium-induced endothelial dysfunction mediated by asymmetric dimethylarginine
por: Al-Naemi, Hamda A., et al.
Publicado: (2020)

Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside
por: Hannemann, Juliane, et al.
Publicado: (2020)

Assessment of asymmetric dimethylarginine and homocysteine in epileptic children receiving antiepileptic drugs
por: Mahmoud, Asmaa A., et al.
Publicado: (2022)

Effect of Resistance Training on Plasma Nitric Oxide and Asymmetric Dimethylarginine Concentrations in Type I Diabetic Rats
por: Esfahani, Parivash Shekarchizadeh, et al.
Publicado: (2013)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o47ktljf7julcrld1vk787t43i